Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 07/27/22
Inari Medical: Fundamentals Soft, Technicals Supportive Of Near-Term Upside CaptureSeeking Alpha • 07/22/22
OKAMI MEDICAL ANNOUNCES FDA 510(k) CLEARANCE OF THE LOBO-7 and LOBO-9 VASCULAR OCCLUDERS TO ADDRESS A WIDE RANGE OF PERIPHERAL EMBOLIZATION CASESPRNewsWire • 06/07/22
Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/05/22
Inari Medical Q1 Earnings Beat Street View, Lifts FY22 Sales Outlook Above ConsensusBenzinga • 05/05/22
Strength Seen in Inari Medical, Inc. (NARI): Can Its 6.2% Jump Turn into More Strength?Zacks Investment Research • 05/02/22
Inari Medical, Inc. (NARI) Up 2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/25/22
Inari Medical Announces Closing of Underwriters' Over-Allotment Option in Connection with Offering of Common StockGlobeNewsWire • 03/21/22
Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/22
Inari Medical to Announce Fourth Quarter and Full-Year 2021 Financial ResultsGlobeNewsWire • 02/10/22